Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Last week, Regenerx was awarded a patent in China for its...
The wheels kept turning last week in China biotech, as...
Shanghai Fosun Pharma has purchased a 6.5% stake in...
CBT 200 Falls 128 Points. More details...
CBT 200 Gives Up 3 Points. More details...
China National Biotechnology Group (CNBG) will raise as...
Shanghai Fosun Pharma's on-again/off-again Hong Kong IPO...
Shanghai Fosun Pharma has been given regulatory approval...
Shanghai Fosun Pharma received a loan totaling 300...
Fosun Pharma’s long-in-the-works IPO on the Hong...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
